Suppr超能文献

ADAM 家族蛋白的结构域整合:结构研究的新主题。

Domain integration of ADAM family proteins: Emerging themes from structural studies.

机构信息

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.

Department of Cancer Biology, Dana Farber Cancer Institute, Boston, MA 02215, USA.

出版信息

Exp Biol Med (Maywood). 2019 Dec;244(17):1510-1519. doi: 10.1177/1535370219865901. Epub 2019 Jul 23.

Abstract

UNLABELLED

ADAM (a disintegrin and metalloproteinase) proteins are type-1 transmembrane and secreted proteins that function in cell adhesion and signal transduction. Here we review the structural features of ADAM proteins that direct their biological functions in ectodomain shedding and cell adhesion.

IMPACT STATEMENT

Recent structural advances have provided a deeper appreciation for interdomain relationships that modulate the activity of ADAM proteins in ectodomain shedding and cellular adhesion. Our review covers these new findings, and places them into historical context. The new results make clear that the metalloproteinase domain works in combination with its ancillary domains to execute its biological function. The ADAM ectodomain is dynamic, and accesses conformations that require interdomain movements during its enzymatic “lifecycle.” Fundamental questions about ADAM activation and substrate selection, however, still remain unanswered. Elucidating the biochemical and structural basis for ADAM regulation will be an exciting avenue of future research that should greatly advance our understanding of ADAM function in biology and human pathogenesis.

摘要

未加标签

ADAM(解整合素和金属蛋白酶)蛋白是 1 型跨膜和分泌蛋白,在细胞黏附和信号转导中发挥作用。本文综述 ADAM 蛋白的结构特征,这些结构特征指导其在细胞外结构域脱落和细胞黏附中的生物学功能。

重要意义

最近的结构进展使人们更深入地了解调节 ADAM 蛋白在细胞外结构域脱落和细胞黏附中活性的域间关系。本文综述涵盖了这些新发现,并将其置于历史背景中。新结果表明,金属蛋白酶结构域与辅助结构域协同作用执行其生物学功能。ADAM 细胞外结构域是动态的,并在其酶“生命周期”中获取需要域间运动的构象。然而,关于 ADAM 激活和底物选择的基本问题仍未得到解答。阐明 ADAM 调节的生化和结构基础将是未来研究的一个令人兴奋的方向,这将极大地促进我们对 ADAM 在生物学和人类发病机制中的功能的理解。

相似文献

1
Domain integration of ADAM family proteins: Emerging themes from structural studies.
Exp Biol Med (Maywood). 2019 Dec;244(17):1510-1519. doi: 10.1177/1535370219865901. Epub 2019 Jul 23.
2
Ectodomain shedding and ADAMs in development.
Development. 2012 Oct;139(20):3693-709. doi: 10.1242/dev.076398.
5
Metalloprotease-induced ectodomain shedding of neural cell adhesion molecule (NCAM).
J Neurobiol. 2006 Oct;66(12):1378-95. doi: 10.1002/neu.20257.
6
A systematic study of modulation of ADAM-mediated ectodomain shedding by site-specific O-glycosylation.
Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):14623-8. doi: 10.1073/pnas.1511175112. Epub 2015 Nov 9.
7
Inhibition of airway smooth muscle adhesion and migration by the disintegrin domain of ADAM-15.
Am J Respir Cell Mol Biol. 2007 Oct;37(4):494-500. doi: 10.1165/rcmb.2006-0364OC. Epub 2007 Jun 15.
8
The "a disintegrin and metalloprotease" (ADAM) family of sheddases: physiological and cellular functions.
Semin Cell Dev Biol. 2009 Apr;20(2):126-37. doi: 10.1016/j.semcdb.2008.11.002. Epub 2008 Nov 13.

引用本文的文献

1
ADAM Proteases in Cancer: Biological Roles, Therapeutic Challenges, and Emerging Opportunities.
Cancers (Basel). 2025 May 19;17(10):1703. doi: 10.3390/cancers17101703.
2
Fully human monoclonal antibody targeting the cysteine-rich substrate-interacting region of ADAM17 on cancer cells.
Biomed Pharmacother. 2024 Nov;180:117605. doi: 10.1016/j.biopha.2024.117605. Epub 2024 Oct 25.
3
Cryo-EM reveals that iRhom2 restrains ADAM17 protease activity to control the release of growth factor and inflammatory signals.
Mol Cell. 2024 Jun 6;84(11):2152-2165.e5. doi: 10.1016/j.molcel.2024.04.025. Epub 2024 May 22.
4
Prediction of anticancer drug sensitivity using an interpretable model guided by deep learning.
BMC Bioinformatics. 2024 May 9;25(1):182. doi: 10.1186/s12859-024-05669-x.
5
Evaluation of Cisplatin-Induced Acute Renal Failure Amelioration Using Fondaparinux and Alteplase.
Pharmaceuticals (Basel). 2023 Jun 21;16(7):910. doi: 10.3390/ph16070910.
6
LGI3/2-ADAM23 interactions cluster Kv1 channels in myelinated axons to regulate refractory period.
J Cell Biol. 2023 Apr 3;222(4). doi: 10.1083/jcb.202211031. Epub 2023 Feb 24.
7
Immunomodulatory role of metalloproteases in cancers: Current progress and future trends.
Front Immunol. 2022 Dec 16;13:1064033. doi: 10.3389/fimmu.2022.1064033. eCollection 2022.
10
ADAM10 and ADAM17-Novel Players in Retinoblastoma Carcinogenesis.
Int J Mol Sci. 2022 Oct 20;23(20):12621. doi: 10.3390/ijms232012621.

本文引用的文献

1
ADAM10 sheddase activation is controlled by cell membrane asymmetry.
J Mol Cell Biol. 2019 Dec 23;11(11):979-993. doi: 10.1093/jmcb/mjz008.
2
The emerging role of ADAM metalloproteinases in immunity.
Nat Rev Immunol. 2018 Dec;18(12):745-758. doi: 10.1038/s41577-018-0068-5.
3
Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments.
EMBO J. 2018 Aug 1;37(15). doi: 10.15252/embj.201899456. Epub 2018 Jul 5.
4
Structural basis of epilepsy-related ligand-receptor complex LGI1-ADAM22.
Nat Commun. 2018 Apr 18;9(1):1546. doi: 10.1038/s41467-018-03947-w.
5
Structural Basis for Regulated Proteolysis by the α-Secretase ADAM10.
Cell. 2017 Dec 14;171(7):1638-1648.e7. doi: 10.1016/j.cell.2017.11.014. Epub 2017 Dec 7.
7
TIMPs: versatile extracellular regulators in cancer.
Nat Rev Cancer. 2017 Jan;17(1):38-53. doi: 10.1038/nrc.2016.115. Epub 2016 Dec 9.
8
An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growth.
J Exp Med. 2016 Aug 22;213(9):1741-57. doi: 10.1084/jem.20151095. Epub 2016 Aug 8.
9
Phosphatidylserine exposure is required for ADAM17 sheddase function.
Nat Commun. 2016 May 10;7:11523. doi: 10.1038/ncomms11523.
10
TspanC8 tetraspanins differentially regulate the cleavage of ADAM10 substrates, Notch activation and ADAM10 membrane compartmentalization.
Cell Mol Life Sci. 2016 May;73(9):1895-915. doi: 10.1007/s00018-015-2111-z. Epub 2015 Dec 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验